Skip to content

Clinical trials

Recruiting Small Cell Lung Carcinoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Recruiting Country / region: China Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20181
20191
20201
20212
20221
202311
202428
202532
202628

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting107

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sichuan Baili Pharmaceutical Co., Ltd.6
Shanghai Pulmonary Hospital, Shanghai, China5
Suzhou Zelgen Biopharmaceuticals Co.,Ltd5
Cancer Institute and Hospital, Chinese Academy of Medical Sciences4
Shanghai Chest Hospital4
Boehringer Ingelheim3
Pfizer3
Akeso2
Amgen2
Anhui Provincial Cancer Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma107
Carcinoma, Non-Small-Cell Lung14
Lung Neoplasms8
Carcinoma, Hepatocellular5
Carcinoma, Neuroendocrine4
Endometrial Neoplasms4
Carcinoma, Renal Cell3
Colorectal Neoplasms3
Melanoma3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.